El Sobrante, CA, United States of America

John G Bauman

USPTO Granted Patents = 23 

Average Co-Inventor Count = 5.2

ph-index = 6

Forward Citations = 99(Granted Patents)


Location History:

  • Alameda, CA (US) (1993 - 2001)
  • El Sobrante, CA (US) (2003 - 2023)

Company Filing History:


Years Active: 1993-2023

Loading Chart...
23 patents (USPTO):Explore Patents

Title: John G. Bauman: Innovator in Ocular Disorders Treatment

Introduction: John G. Bauman, an accomplished inventor based in El Sobrante, California, has made significant contributions to the field of medicinal chemistry, particularly in the treatment of ocular disorders. With a portfolio of 23 patents, Bauman's work focuses on innovative therapeutics that aim to improve the quality of life for individuals affected by various eye conditions.

Latest Patents: Some of Bauman’s most recent patents include "Drugs and Compositions for the Treatment of Ocular Disorders." This invention provides novel prodrugs of therapeutically active compounds designed to address disorders associated with increased intraocular pressure, such as glaucoma, along with other conditions requiring neuroprotection, including age-related macular degeneration and diabetic retinopathy. Another notable patent is "Compounds and Compositions for the Treatment of Ocular Disorders," which describes prodrugs and derivatives of various classes of drugs, including prostaglandins and carbonic anhydrase inhibitors, aimed at enhancing the treatment efficacy for ocular diseases through controlled delivery formulations.

Career Highlights: Throughout his career, John G. Bauman has held significant positions at prominent companies. Notably, he has worked at Schering Aktiengesellschaft, a global leader in pharmaceuticals, and at Graybug Vision, Inc., where he contributed his expertise in the development of innovative therapies for eye disorders. His extensive experience in the pharmaceutical industry has allowed him to drive advancements in ocular health.

Collaborations: Bauman has collaborated with esteemed professionals such as Brad Owen Buckman and Ameen F. Ghannam. These partnerships have been pivotal in pooling knowledge and resources to advance therapeutic innovations in their shared field of interest.

Conclusion: John G. Bauman is a notable inventor whose work continues to impact the treatment landscape for ocular disorders. His innovative patents and collaborations highlight a dedicated pursuit of developing therapies that address significant medical needs, ultimately improving patient outcomes in the realm of eye health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…